Alvotech (NASDAQ:ALVOW – Get Free Report) was the target of a large decrease in short interest in January. As of January 15th, there was short interest totaling 1,076 shares, a decrease of 30.7% from the December 31st total of 1,552 shares. Based on an average daily trading volume, of 698 shares, the short-interest ratio is currently 1.5 days. Based on an average daily trading volume, of 698 shares, the short-interest ratio is currently 1.5 days.
Alvotech Price Performance
Shares of ALVOW opened at $0.43 on Friday. Alvotech has a 1-year low of $0.41 and a 1-year high of $3.00. The firm has a fifty day moving average price of $0.65 and a 200 day moving average price of $1.10.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Read More
- Five stocks we like better than Alvotech
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
